LRBA, a BEACH protein mutated in human immune deficiency, is widely expressed in epithelia, exocrine and endocrine glands, and neurons

Eleni Roussa(University of Freiburg), Manfred W. Kilimann(Max Planck Institute for Political and Social Science), Ursula Seidler(Medizinische Hochschule Hannover), Markus Sjöblom(Uppsala University), Michael Laue(Robert Koch Institute), Pavel Jůda(Charles University), Wolfgang Meyerhof(German Institute of Human Nutrition), Katerina Nikolovska(Medizinische Hochschule Hannover), Oliver Mai(Saarland University)
Scientific Reports
May 9, 2024
10.1038/s41598-024-60257-6
Cited by 7

Related Papers

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
|PLoS ONE|2007|478
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
|The Lancet|2017|449
Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II
|Science|1996|409